News search
 Research 7 Nov 2022 A CNIC study reveals that mutations previously identified in the gene MINDBOMB1 (MIB1) as causing non-compaction cardiomyopathy either provoke this disease or valve defects, depending on their combination with mutations in modifier genes |
 Research 17 Mar 2022 The mixing of mitochondrial DNAs (mtDNAs) of two distinct origins can have damaging medium- and long-term effects, according to the results of a new study published in Circulation |
 Research 26 Oct 2021 Scientists from the CNIC and the CIBERCV have generated the first experimental animal model that develops Hutchinson-Gilford Progeria Syndrome and allows its controlled reversal |
 Research 3 Sep 2021 The new findings, published in Circulation Research, could spur the development of new tools for the treatment of cardiac hypertrophy |
 Research 9 Oct 2019 Treatment of mice for 12 months with the anticoagulant drug dabigatran prevented memory loss and preserved cerebral circulation |
 Research 12 Sep 2019 The new study was conducted by investigators at the CNIC, the Hospital Clínico San Carlos in Madrid, and the CiberCV research network and is featured on the cover of the latest edition of the journal Circulation Research |
 Research 5 Sep 2019 Scientists at the Centro Nacional de Investigaciones Cardiovasculares (CNIC) and Puerta de Hierro hospital in Majadahonda have found a possible treatment for this disease |
 Research 4 Jul 2019 A new study published in Circulation Research shows that loss of cardiac expression of SRSF3 leads to a critical reduction in the expression of genes related to contraction |
 Research 8 Jan 2019 The expression on lymphocytes of the molecule CD69 inversely predicts the development of subclinical (symptom-free) atherosclerosis independently of classical cardiovascular risk factors |
 Research 5 Mar 2018 Investigadores del CNIC, del CIBERCV y de la Universidad de Oviedo han creado el primer modelo de ratón con aterosclerosis acelerada por la proteína progerina |
- ‹ previous
- 2 of 3
- next ›
